Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
23 Leser
Artikel bewerten:
(0)

Technical Updates, Finalized Deals, and Inclusion and Diversity Reports - Analyst Notes on Exelon, Sempra Energy, AES, NiSource and Ameren

NEW YORK, June 18, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Exelon Corporation (NYSE: EXC), Sempra Energy (NYSE: SRE), AES Corp (NYSE: AES), NiSource Inc. (NYSE: NI) and Ameren Corp (NYSE: AEE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3835-100free.

--
Exelon Corporation Analyst Notes
On June 13, 2014, Exelon Corporation's (Exelon) stock gained 1.85% to close trading at $35.72. Over the past month of trading, Exelon's stock increased by 0.25% while the Dow Jones Industrial Average also gained 0.36% during that period. The full analyst notes on Exelon are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/EXC/report.pdf

--
Sempra Energy Analyst Notes
On June 13, 2014, shares of Sempra Energy ended trading at $101.12 to reflect a 1.39% gain. On the same date, Nasdaq reported that Sempra Energy's Mexican unit Infraestructura Energetica Nova SAB has received a loan worth $270 million for the completion of the first phase of its wind energy generation project called Energia Sierra Juarez. Over the past five trading days, the Company's shares increased 0.41% compared to the S&P 500 which dropped 0.68% over the same period. The full analyst notes on Sempra Energy are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/SRE/report.pdf

--
AES Corp Analyst Notes
On June 13, 2014, AES Corp (AES) announced that it has finalized the previously disclosed sale of its entire equity interest in all three businesses in Cameroon to pan-emerging market investor Actis for $202 million (net of closing price adjustments). The Company stated that in line with the sales agreement, it has received $162 million at closing while the remaining non-contingent $40 million will be received in June 2016. The full analyst notes on AES are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/AES/report.pdf

--
NiSource Inc. Analyst Notes
On June 4, 2014, NiSource Inc. (NiSource) released its 2013 Inclusion and Diversity (I&D) report which details the Company's commitment, ongoing strategy and achievements through four dimensions of I&D: employees, customers, communities and supplier diversity. NiSource President and CEO Robert C. Skaggs, Jr. stated, "I&D is more than a program at NiSource; it's an ongoing, strategic direction that is part of who we are and how we operate. It's about how we think, how we act, and how we speak with one another - how we treat our customers, coworkers and others with whom we do business." The Company's I&D report highlights include: Building connections, strengthening teams - where more than 2000 employees are actively involved in I&D efforts via diversity councils, mentoring programs, community events and employee resource groups (ERGs); Providing better customer service; Improving communities; and Building economic inclusion with diverse suppliers. The full analyst notes on NiSource are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/NI/report.pdf

--
Ameren Corp Analyst Notes
On June 13, 2014, Ameren Corp's (Ameren) stock increased 0.34% to close trading at $38.40. Over the past 3-month trading period, Ameren's stock fell 5.96% while the Dow Jones Industrial Average gained 4.13% during the same period. The full analyst notes on Ameren are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/AEE/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


AnalystsReview.com

SOURCE Analysts Review

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.